[EN] BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5<br/>[FR] INHIBITEURS HÉTÉROAROMATIQUES BICYCLIQUES DE LA KLK5
申请人:BIOCRYST PHARM INC
公开号:WO2022221526A1
公开(公告)日:2022-10-20
Disclosed are compounds of formulae (I) - (IV), and pharmaceutically acceptable salts thereof, which are inhibitors of kallikrein-related peptidase 5 (KLK5). Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant KLK5 activity activity, such as Netherton Syndrome.
本发明涉及式(I)-(IV)的化合物及其药学上可接受的盐,这些化合物是卡利肯酶相关肽酶5(KLK5)的抑制剂。还提供了包含这种化合物的制药组合物以及使用这些化合物和组合物治疗或预防由异常KLK5活性引起的疾病或病状的方法,例如Netherton综合症。